JIUYUAN GENE Finalises Corporate Rebranding to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

Bulletin Express
05/11

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (stock short name: JIUYUAN GENE) has completed its previously announced corporate name change. According to the board announcement dated 11 May 2026, the Registrar of Companies in Hong Kong issued a Certificate of Registration of Alteration of Name on 17 April 2025, confirming the switch from “Hangzhou Jiuyuan Gene Engineering Co., Ltd.” to “Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.” The Chinese name was simultaneously updated from “杭州九源基因工程股份有限公司” to “杭州九源基因生物醫藥股份有限公司”.

The rebranding does not affect shareholder rights, daily operations or the company’s financial position. All existing share certificates bearing the former name remain valid for trading, settlement, registration and delivery. From 15 April 2025, newly issued share certificates carry the new corporate name; there is no arrangement for exchanging previously issued certificates.

The company’s stock code (02566) and its Chinese (九源基因) and English (JIUYUAN GENE) trading abbreviations remain unchanged.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10